Non-Epithelioid Mesothelioma: Immunotherapy Combo Could be the New Standard of Care
Two immunotherapy drugs could become the new standard of care for people with non-epithelioid mesothelioma. All forms of malignant mesothelioma…
Get the latest details on current events, medical progress, and therapies used by mesothelioma patients around the globe. Learn More.